DaVita Profile

63.75
USD 0.66  1.05%
8%
31%

Sale by James Hilger of 971 shares of DaVita

DaVita insider trading alert for sale of common stock by James Hilger, Chief Accounting Officer, on April 23, 2018. This event was filed by Davita Inc with SEC on 2011-03-11. Statement of changes in beneficial ownership - SEC Form 4. James Hilger is currently serves as interim cfo and chief accounting officer of DaVita [view details]   

DaVita Summary

DaVita (DVA) is traded on New York Stock Exchange in USA. It is located in COLORADO, U.S.A and employs 74,500 people. DaVita is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 11.43 B. DaVita runs under Healthcare sector within Healthcare Services industry. This company has 181.22 M outstanding shares of which 0 shares are currently shorted by investors with about 0.0 days to cover shorted positions. DAVITA INC has about 551.75 M in cash with 1.05 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03.
Check DaVita Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 16.46%30 days 63.75  about 83.41%
Based on normal probability distribution, the odds of DaVita to move above current price in 30 days from now is about 83.41% (This DaVita probability density function shows the probability of DaVita Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bank Of MontrealCommon Shares255 K16.8 M
Dnb Asset Management AsCommon Shares226 K14.9 M
View DaVita Diagnostics

Selected DaVita Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DaVita Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for DaVita are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado. DaVita operates under Specialized Health Services classification in USA and traded on New York Stock Exchange. It employs 74500 people. more
Fama & French Healthcare
Healthcare
Fama & French Classification
NameDaVita
CEO of Kidney Care DivisionJavier RodriguezView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Healthcare Services
InstrumentUSA Stock View All
RegionNorth America
LocationCOLORADO, U.S.A
Business Address2000 16th Street
ExchangeNew York Stock Exchange
CIK Number00927066.0
ISINUS23918K1088
CUSIP23918K108
SectorHealthcare
IndustryHealthcare Services
BenchmarkDOW
Websitewww.davita.com
Contact Number303 405 2100
CurrencyUSD - US Dollar

Current Sentiment - DVA

DaVita Investor Sentiment
Greater number of Macroaxis users are currently bullish on DaVita. What is your opinion about investing in DaVita? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Recommendations

DaVita Analyst Recommendations
Target PriceAdvice# of Analysts
66.83Hold6Odds
DaVita current and past analyst recommendations published by number of research institutions as well as average analyst consensus
DaVita Analyst Advice  

Earnings

DaVita Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82May 3, 2017
DaVita normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

DaVita Corporate Directors
Paul Diaz Independent Director
John Nehra Independent Director
Peter Grauer Lead Independent Director
Additionally see Investing Opportunities. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.